Stock SUCAMPO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Sucampo Pharmaceuticals, Inc.

Equities

US8649091068

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors
GL
Sucampo Pharmaceuticals, Inc. : Sucampo and Clinigen Announce Named Patient Program for European Union, Iceland and Norway to Provide Access to AMITIZA(R) (lubiprostone) for Chronic Idiopathic Constipation Patients
PU
Sucampo Pharmaceuticals, Inc. : Sucampo and Clinigen Announce Named Patient Program for European Union, Iceland and Norway to Provide Access to AMITIZA® (lubiprostone) for Chronic Idiopathic Constipation Patients
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Sucampo Pharmaceuticals, Inc.
  5. Insiders